Oaktree Capital Management’s Thrive Acquisition Corporation Class A ordinary shares THAC Stock Holding History

Oaktree Capital Management’s Portfolio THAC Stock Details THAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$1.03M	–	374
2022 Q4	$1.03M	Hold	100,000	–	–	0.01%	309
2022 Q3	$1.01M	Hold	100,000	–	–	0.01%	330
2022 Q2	$1M	Hold	100,000	–	–	0.01%	315
2022 Q1	$1M	Sell	100,000 -100,000	-50%	-$995K	0.01%	306
2021 Q4	$1.98M	Buy	+200,000	New	+$1.98M	0.02%	241

Oaktree Capital Management's THAC Position: Q1 2023 in Review

Oaktree Capital Management sold out of Thrive Acquisition Corporation Class A ordinary shares (THAC) in Q1 2023, closing a stake of 100,000 shares — an estimated $1.03M sold.

Oaktree Capital Management first reported a position in THAC in Q4 2021 and held it in 5 quarters. The position peaked at $1.98M in Q4 2021. 0 funds tracked by Wall St. Rank hold THAC as of Q1 2023.

Oaktree Capital Management reported no remaining Thrive Acquisition Corporation Class A ordinary shares position as of Q1 2023 after selling out during the quarter.
Oaktree Capital Management sold 100,000 Thrive Acquisition Corporation Class A ordinary shares shares in Q1 2023, an estimated $1.03M.
Oaktree Capital Management first reported a position in Thrive Acquisition Corporation Class A ordinary shares in Q4 2021 and held it in 5 quarters.
Oaktree Capital Management's Thrive Acquisition Corporation Class A ordinary shares position peaked at $1.98M in Q4 2021.
0 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Class A ordinary shares as of Q1 2023.

Based on Oaktree Capital Management's 13F filing for Q1 2023, filed 15 May 2023.